Tracey Mc Cain
About Tracey Mc Cain
Tracey L. McCain Executive Profile
Tracey L. McCain currently serves as the Executive Vice President and Chief Legal and Compliance Officer for a major biopharmaceutical enterprise. With over 25 years of legal, management, and transactional experience within the industry, she plays a pivotal role in guiding legal and compliance strategies. Her extensive background in overseeing legal departments and steering complex transactions showcases her essential contributions to the biopharmaceutical sector.
Tracey L. McCain Education and Academic Credentials
Tracey L. McCain holds a Bachelor of Arts in Political Science from the University of Pennsylvania. Furthermore, she earned a Juris Doctor degree from Columbia University School of Law. These academic achievements laid the foundation for her comprehensive understanding of legal principles and her subsequent career in the biopharmaceutical industry.
Tracey L. McCain's Role at Sanofi Genzyme
Tracey L. McCain served as the Senior Vice President and Head of Legal for Sanofi Genzyme. During her tenure, she was a member of the executive leadership team and played a crucial role within Sanofi's global legal department. Her responsibilities included managing the U.S. and European legal departments, covering general corporate, commercial, and intellectual property matters, and supporting business development initiatives. She also led securities and employment law teams and facilitated non-patent litigation processes.
Tracey L. McCain's Early Legal Career
Prior to her roles in the biopharmaceutical industry, Tracey L. McCain began her legal career as an associate at Palmer & Dodge LLP. This early experience provided her with a solid grounding in legal practice, which she later applied to her expansive work in legal management and compliance within the biopharmaceutical field.
Board Memberships and Trustee Roles of Tracey L. McCain
Tracey L. McCain sits on the boards of directors at Kiniksa Pharmaceuticals and ImmunoGen, contributing her extensive legal and industry expertise. Additionally, she is a member of the board of trustees at Dana Farber Cancer Institute. Her role in these organizations underlines her commitment to advancing both the biopharmaceutical industry and healthcare initiatives.